10.1002/adsc.201901465
Advanced Synthesis & Catalysis
Methyl
(2R,3R,4R,5S)-4-(5,5-difluoro-5H-44,54-
Flow cytometry assay. After the treatment the cells were
trypsinized for 5 min, then the process stopped with
complete medium. The cells were washed with PBS and
centrifugated with 177× g for 5 min in an Eppendorf
centrifuge 5804 R (Eppendorf, Hamburg, Germany). The
process was done twice. After that, the cells were analyzed
in a Beckman Coulter Cytomics 500 Flow Cytometer
(Beckman Coulter, Indianapolis, IN, USA) using 20000
cells.
dipyrrolo[1,2-c:2',1'-f][1,3,2] diazaborinin-10-yl)-3,5-
diphenylpyrrolidine-2-carboxylate (3a)
Pyrrolidine 3a was obtained following the general
procedure, from BODIPY 2a and imine 1a, after
purification by flash chromatography (CyHex:EtOAc =
2:1) as a red solid (42 mg, 89% yield). [α]20 = - 139 (c =
D
0.035, CHCl3). 1H NMR (500 MHz, CDCl3, 278 K): δ 7.80
(br s, 1H), 7.73 (br s, 1H), 7.62 (br s, 1H), 7.45 – 7.41 (m,
2H), 7.33 – 7.18 (m, 8H), 6.65 (br s, 2H), 6.20 (br s, 1H),
4.87 (d, J = 9.8 Hz, 1H), 4.68 (d, J = 9.4 Hz, 1H), 4.33 (t, J
= 9.5 Hz, 1H), 3.87 (t, J = 9.7 Hz, 1H), 3.25 (s, 3H), 3.02
(br s, 1H). 13C NMR (126 MHz, CDCl3, 278 K): δ 172.6,
148.2, 145.8, 141.8, 139.5, 139.0, 137.2, 132.3, 129.7,
129.0, 128.7, 128.5, 127.8, 127.7, 127.6, 126.4, 118.8,
118.0, 72.5, 65.9, 59.7, 58.8, 51.9. 19F NMR (282 MHz,
CDCl3, 298 K): δ -145.6 – -145.9 (m, 2F). HRMS (ESI+):
Acknowledgements
This work was supported by the Spanish Government (RTI2018-
095038-B-I00,
CTQ2016-76061-P,
SAF2017-87305-R),
Comunidad de Madrid (IND2017/IND-7809), and co-financed by
European Structural and Investment Fund. We acknowledge the
generous allocation of computing time at the CCC (UAM).
Financial support from the Spanish Ministry of Economy and
Competitiveness, through the ‘‘Maria de Maeztu’’ Program of
Excellence in R&D (MDM-2014-0377), is also acknowledged.
Asociación Española Contra el Cáncer, and IMDEA Nanociencia
acknowledge support from the 'Severo Ochoa' Programme for
Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686).
F. E. and A. G. thank the Spanish Government for FPI-PhD.
fellowships and E.M.A for FPU-PhD fellowship. P.M.R thanks
the Ministry of Economy, Industry and competitiveness of Spain
for the FPI grant (BES-2017.082521). A.M.S. thanks CAM for a
postdoctoral contract (2016-T2/IND-1660).
calculated for C27H25BF2N3O2 , [M+H]+ = 472.2002; found
+
= 472.2008. The enantiomeric excess was determined by
HPLC on a Chiralpak IB column: n-Hex/i-PrOH 40:60,
flow rate 1.0 mL/min, λ = 495 nm, major = 12.06 min, minor
= 7.06 min (98% ee).
Computational details
Geometry optimizations, orbital energies, harmonic
frequency calculations, thermodynamic corrections and
intrinsic reaction coordinate (IRC) calculations were
computed with B3LYP functional combined with Pople’s
double- basis set 6-31G(d,p), which includes polarization
functions. Harmonic vibrational frequencies were
computed to characterize minima and transition states (TS)
and IRCs to verify connectivity between TSs and adjacent
minima at the same level of theory - B3LYP/6-31G(d,p).
More accurate values for the final energies were computed
by means of single point calculations with -B97X-D
functional and a larger, triple-, basis set including diffuse
functions, 6-311+G(d,p), over the geometries previously
optimized. The range-separated hybrid functional -B97X-
D includes Grimme’s D2 dispersion correction, absent in
B3LYP functional. The effect of the solvent (CH2Cl2) was
also taken into account using the SMD continuum
solvation model.
References
[1] a) S. Kolemen, E. U. Akkaya, Coord. Chem. Rev. 2018,
354, 121-134; b) S. Krajcovicova, J. Stankova, P.
Dzubak, M. Hajduch, M. Soural, M. A. Urban, Chem.
Eur. J. 2018, 24, 4957-4966; c) R. Lincoln, L. E.
Greene, W. Zhang, S. Louisia, G. Cosa, J. Am. Chem.
Soc. 2017, 139, 16273-16281; d) T. Kowada, H. Maeda,
K. Kikuchi, Chem. Soc. Rev. 2015, 44, 4953-4972; e) P.
Rivera-Fuentes, S. J. Lippard, Acc. Chem. Res. 2015,
48, 2927-2934; f) Y. Ni, J. Wu, Org. Biomol. Chem.
2014, 12, 3774-3791.
Biological studies
Viability assays: alamar blue. After treating the cells
with the solutions of the compounds, a stock solution of
resazurin sodium salt (Sigma-Aldrich, St. Louis, MO,
USA) (1 mg/mL) in PBS was diluted 1% (v/v) in complete
RPMI medium and added to the cells. After 3 h in the
incubator (37 ˚C), the fluorescence was measured at 25 ˚C
in a plate reader Synergy H4 Hybrid reader (BioTEK) λex
= 550 nm, λem = 590 nm. The fluorescent intensity
measurements were processed using the following
equation: % Cell viability = ((Sample data - Negative
control) / (Positive control - Negative control)) ×100. The
positive control corresponds with untreated cells. A
resazurin solution without cells was used as negative
control.
[2] a) G. Ulrich, R. Ziessel, A. Harriman, Angew. Chem.
Int. Ed. 2008, 47, 1184-1201; b) N. Boens, V. Leen, W.
Dehaen, Chem. Soc. Rev. 2012, 41, 1130-1172; c) A.
Loudet, K. Burgess, Chem. Rev. 2007, 107, 4891-4932.
[3] N. Boens, B. Verbelen, W. Dehaen, Eur. J. Org. Chem.
2015, 6577-6595.
[4] a) W. Wang, M. M. Lorion, O. Martinazzoli, L.
Ackermann, Angew. Chem. Int. Ed. 2018, 57, 10554-
10558; b) L. Mendive-Tapia, C. Zhao, A. R. Akram, S.
Preciado, F. Albericio, M. Lee, A. Serrels, N. Kielland,
N. D. Read, R. Lavilla, M. Vendrell, Nat. Commun.
2016, 7, 10940.
Localization assay. The cells were harvested on coverslips.
Then the bodipys were added in a final concentration of 10
µM. 24h later the cells were washed twice with PBS.
Finally, 48 h after the treatment LisoTracker red DND-99
was dissolved in optiMEM to 50 nM final concentration.
The solution was incubated 5 min with the cells at room
temperature and the cells were then washed twice with
PBS. Then, the samples were studied in a Leica DMI3000
M inverted microscope (Leica, Wetzlar, Germany) at 800
exposure units. The bodibys signal was observed with the
green filter of the microscope (λex 460-500 nm; λem 515-
545 nm) and the lysotracker with the red filter (λex 540-580
nm; λem 615-680 nm). The images were modified for a
correct visualization with Fiji-Image J program.
[5] a) P. S. Deore, D. V. Soldatov, R. A. Manderville, Sci.
Rep. 2018, 8, 16874; b) M. H. Y. Cheng, H. Savoie, F.
Bryden, R. W. Boyle, Photochem. Photobiol. Sci. 2017,
16, 1260-1267; c) N. Zhao, T. M. Williams, Z. Zhou, F.
R. Fronczek, M. Sibrian-Vazquez, S. D. Jois, M. G. H.
Vicente, Bioconjugate Chem. 2017, 28, 1566−1579; d)
L. C. D. de Rezende, F. A. da Silva Emery, Orbital
Elec. J. Chem. 2013, 5, 62-83.
[6] a) A. A. Morgan, E. Rubenstein, PLOS One 2013, 8,
e53785; b) G. Wu, F. W. Bazer, R. C. Burghardt, G. A.
10
This article is protected by copyright. All rights reserved.